CuraTeQ Biologics completes Phase 1 Pharmacokinetics study of biosimilar Denosumab
This study enrolled a total of 204 healthy volunteers into three groups to compare BP16 with the reference products, Prolia, obtained from both the EU and US markets
This study enrolled a total of 204 healthy volunteers into three groups to compare BP16 with the reference products, Prolia, obtained from both the EU and US markets
Subscribe To Our Newsletter & Stay Updated